200 related articles for article (PubMed ID: 17616687)
21. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
23. [Gadd45 mediated G2/M cell cycle arrest induced by BRCA1].
Song YM; Tong T; Fu M; Dong LJ; Jin SQ; Wu M; Zhan QM
Ai Zheng; 2004 May; 23(5):517-21. PubMed ID: 15142446
[TBL] [Abstract][Full Text] [Related]
24. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
Slebos RJ; Taylor JA
Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982
[TBL] [Abstract][Full Text] [Related]
25. Dysfunctional BRCA1 is only indirectly linked to multiple centrosomes.
Hut HM; Rembacz KP; van Waarde MA; Lemstra W; van Cappellen WA; Kampinga HH; Sibon OC
Oncogene; 2005 Nov; 24(51):7619-23. PubMed ID: 16205648
[TBL] [Abstract][Full Text] [Related]
26. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint.
Marquez N; Chappell SC; Sansom OJ; Clarke AR; Court J; Errington RJ; Smith PJ
Oncogene; 2003 Oct; 22(48):7642-8. PubMed ID: 14576827
[TBL] [Abstract][Full Text] [Related]
27. The role of DNA mismatch repair in drug resistance.
Fink D; Aebi S; Howell SB
Clin Cancer Res; 1998 Jan; 4(1):1-6. PubMed ID: 9516945
[TBL] [Abstract][Full Text] [Related]
28. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents.
Vernole P; Pepponi R; D'Atri S
Cancer Chemother Pharmacol; 2003 Sep; 52(3):185-92. PubMed ID: 12827294
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
30. Signalling cell cycle arrest and cell death through the MMR System.
O'Brien V; Brown R
Carcinogenesis; 2006 Apr; 27(4):682-92. PubMed ID: 16332722
[TBL] [Abstract][Full Text] [Related]
31. Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation.
Gurkan E; Schupp JE; Aziz MA; Kinsella TJ; Loparo KA
Cancer Res; 2007 Nov; 67(22):10993-1000. PubMed ID: 18006845
[TBL] [Abstract][Full Text] [Related]
32. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
33. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.
Wang RH; Yu H; Deng CX
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17108-13. PubMed ID: 15563594
[TBL] [Abstract][Full Text] [Related]
34. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.
Fan S; Yuan R; Ma YX; Meng Q; Goldberg ID; Rosen EM
Oncogene; 2001 Dec; 20(57):8215-35. PubMed ID: 11781837
[TBL] [Abstract][Full Text] [Related]
35. Roles of MSH2 and MSH6 in cadmium-induced G2/M checkpoint arrest in Arabidopsis roots.
Cao X; Wang H; Zhuang D; Zhu H; Du Y; Cheng Z; Cui W; Rogers HJ; Zhang Q; Jia C; Yang Y; Tai P; Xie F; Liu W
Chemosphere; 2018 Jun; 201():586-594. PubMed ID: 29533809
[TBL] [Abstract][Full Text] [Related]
36. Methylation damage response in hematopoietic progenitor cells.
Casorelli I; Pelosi E; Biffoni M; Cerio AM; Peschle C; Testa U; Bignami M
DNA Repair (Amst); 2007 Aug; 6(8):1170-8. PubMed ID: 17507295
[TBL] [Abstract][Full Text] [Related]
37. Comet sensitivity in assessing DNA damage and repair in different cell cycle stages.
McArt DG; McKerr G; Saetzler K; Howard CV; Downes CS; Wasson GR
Mutagenesis; 2010 May; 25(3):299-303. PubMed ID: 20159793
[TBL] [Abstract][Full Text] [Related]
38. 6-Thioguanine-induced DNA damage as a determinant of cytotoxicity in cultured Chinese hamster ovary cells.
Christie NT; Drake S; Meyn RE; Nelson JA
Cancer Res; 1984 Sep; 44(9):3665-71. PubMed ID: 6204746
[TBL] [Abstract][Full Text] [Related]
39. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
40. The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents.
Rasmussen LJ; Rasmussen M; Lützen A; Bisgaard HC; Singh KK
Exp Cell Res; 2000 May; 257(1):127-34. PubMed ID: 10854060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
